Filing Details
- Accession Number:
- 0001127602-25-012782
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-30 13:24:38
- Reporting Period:
- 2025-04-29
- Filing Date:
- 2025-04-30
- Accepted Time:
- 2025-04-30 13:24:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 785161 | Encompass Health Corp | EHC | Services-Hospitals (8060) | 630860407 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1186879 | E Douglas Coltharp | 9001 Liberty Parkway Birmingham AL 35242 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Encompass Health Common Stock | Acquisiton | 2025-04-29 | 16,075 | $29.06 | 76,410 | No | 4 | M | Direct | |
| Encompass Health Common Stock | Acquisiton | 2025-04-29 | 27,500 | $32.94 | 103,910 | No | 4 | M | Direct | |
| Encompass Health Common Stock | Disposition | 2025-04-29 | 26,239 | $114.78 | 77,671 | No | 4 | S | Direct | |
| Encompass Health Common Stock | Disposition | 2025-04-29 | 13,402 | $115.51 | 64,269 | No | 4 | S | Direct | |
| Encompass Health Common Stock | Disposition | 2025-04-29 | 3,934 | $116.36 | 60,335 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Encompass Health Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2025-04-29 | 16,075 | $0.00 | 16,075 | $29.06 |
| Encompass Health Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2025-04-29 | 27,500 | $0.00 | 27,500 | $32.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-26 | 2026-02-26 | No | 4 | M | Direct |
| 27,694 | 2019-10-28 | 2026-10-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Encompass Health Common Stock | 125,631 | Indirect | By irrevocable trust for the benefit of children |
| Encompass Health Common Stock | 65,229 | Indirect | By spouse |
Footnotes
- This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.22 to $115.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.22 to $116.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.22 to $116.57, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner ofthe securities for purposes of Section 16 or for any other purpose.
- The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the commonstock of Enhabit, Inc.
Billionaire Hedge Funds
